BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2022 8:25:28 AM | Browse: 447 | Download: 1236
 |
Received |
|
2021-03-26 23:26 |
 |
Peer-Review Started |
|
2021-03-26 23:28 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-06-14 01:31 |
 |
Revised |
|
2021-07-12 22:45 |
 |
Second Decision |
|
2022-03-11 06:06 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-03-16 09:33 |
 |
Articles in Press |
|
2022-03-16 09:33 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-04-01 11:03 |
 |
Publish the Manuscript Online |
|
2022-04-15 08:25 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Editorial |
Article Title |
Liquid biopsy in colorectal cancer: No longer young, but not yet old
|
Manuscript Source |
Invited Manuscript |
All Author List |
Giandomenico Roviello, Daniele Lavacchi, Lorenzo Antonuzzo, Martina Catalano and Enrico Mini |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Giandomenico Roviello, MD, PhD, Assistant Professor, Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Firenze 50139, Italy. giandomenico.roviello@unifi.it |
Key Words |
Colorectal cancer; Liquid biopsy; Circulating tumor DNA; Diagnosis; Prognosis; Targeted therapy |
Core Tip |
Liquid biopsy through analysis of biological components, such as circulating nuclear acids, circulating tumor cells, and more recently exosomes in body fluids, has shown good capacity to overcome several limitations faced by conventional tissue biopsies, in particular invasiveness and unrepeatability. Liquid biopsy has shown significant results in clinical applications in different types of cancer, especially colorectal cancer (CRC). Indeed, liquid biopsy can be used to detect CRC at an early stage, make treatment decisions, monitor response to treatment, predict relapses and metastases, reveal tumor heterogeneity, and detect minimal residual disease. |
Publish Date |
2022-04-15 08:25 |
Citation |
Roviello G, Lavacchi D, Antonuzzo L, Catalano M, Mini E. Liquid biopsy in colorectal cancer: No longer young, but not yet old. World J Gastroenterol 2022; 28(15): 1503-1507 |
URL |
https://www.wjgnet.com/1007-9327/full/v28/i15/1503.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v28.i15.1503 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345